Skip to main content
. 2022 Mar 29;20:101408. doi: 10.1016/j.tranon.2022.101408

Fig. 3.

Fig 3

Hazard Ratio (HR) For Overall Survival (OS) and Response Rates Differences In Selected Randomized Trials In First-Line Advanced Or Metastatic Melanoma.